Advisory Highlights:
- A new American Heart Association presidential advisory identifies the strong connections among cardiovascular disease (CVD), kidney disease, Type 2 diabetes and obesity, and suggests redefining CVD risk, prevention and management.
- The advisory defines cardiovascular-kidney-metabolic (CKM) syndrome for the first time.
- CKM syndrome ranges from Stage 0, or no risk factors and an entirely preventive focus, to Stage 4, the highest-risk stage with cardiovascular disease. Stage 4 may also include kidney failure.
- The advisory urges use of a new tool that will predict someone’s likelihood of heart attack, stroke and/or heart failure in 10 and 30 years.
Embargoed until 4 a.m. CT / 5 a.m. ET Monday, Oct. 9, 2023
DALLAS, Oct. 9, 2023 — Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
Various aspects of cardiovascular disease that overlap with kidney disease, Type 2 diabetes and obesity support the new approach. For the first time, the American Heart Association defines the overlap in these conditions as…
